person

Almudena D.

Country
Spain
Department
Allergy

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 16 partner sites.

Specializations

Multiple Myeloma

Investigator engages in therapeutic strategies for multiple myeloma across disease stages.

  • Immunotherapy
  • Combination regimens
  • Stem cell transplantation

Emphasis placed on achieving deep remission in relapsed or refractory multiple myeloma.

Acute Myeloid Leukemia

Research targets molecular vulnerabilities in acute myeloid leukemia for patients unsuitable for intensive therapy.

  • Targeted inhibitors
  • Venetoclax‑based combinations
  • Quizartinib

Goal includes improving survival in AML with high‑risk features.

Higher‑Risk Myelodysplastic Syndromes

Clinical focus addresses disease transformation risk in higher‑risk myelodysplastic syndrome.

  • Azacitidine
  • Venetoclax
  • Lisaftoclax

Therapeutic intent is to delay progression to acute leukemia.

Allergic Rhinitis and Asthma

Evaluation of subcutaneous allergen extracts for allergic rhinitis. Studies also consider comorbid asthma control.

  • Allergen immunotherapy
  • Pollen vaccine
  • ARIA‑guided outcomes

Outcomes measured include symptom reduction in rhinitis/rhinoconjunctivitis.

Non‑Small Cell Lung Cancer

Efforts concentrate on targeted and immunologic options for advanced non‑small cell lung cancer.

  • PD‑1 blockade
  • Pembrolizumab biosimilar
  • Combination regimens

Aim is to extend overall survival in metastatic NSCLC.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.